Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Neptune Pharma is a UK-based specialty pharmaceutical company focused on the development, licensing, and commercialization of niche medicines and value-added products. The company specializes in therapeutic areas such as endocrinology, haematology, and women's health, with a particular emphasis on addressing unmet needs in vitamin and mineral deficiencies. Its lead commercial product, Desitrol, is a high-strength Vitamin D3 (colecalciferol) supplement used for the treatment and prevention of Vitamin D deficiency. Neptune Pharma's business model involves identifying gaps in the market for established molecules and developing optimized formulations or delivery methods to improve patient outcomes. The company maintains a robust pipeline of niche products aimed at providing cost-effective and clinically effective solutions for the UK healthcare market.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Neptune Pharmaceuticals.